An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics: A pilot project
Phase 1 was successfully completed. The RST presents several distinct aspects compared with other tools, including its scoring scale and method, and capacity to factor in incomplete or pending information. It is anticipated that the framework used for the RST will lend itself to use in other dynamic situations involving many interventions.
Authors
- L Béïque
- S.K.R. Clarke
- Elaha Sarwar
- Margaret Gale-Rowe
- Stacy Sabourin
- Cheryl Marinsky
- Mina Azad
- Jacqueline Arthur
Institutions
- Public Health Agency of Canada (CA)
Publication Details
- Journal
- Canada Communicable Disease Report
- Published
- 2024-10-03
- DOI
- https://doi.org/10.14745/ccdr.v50i10a04
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Public Health Agency of Canada
- Public Health Agency